The role of acid in the pathogenesis of indomethacin-induced gastric antral ulcers in the rat

被引:11
作者
Clayton, NM
Oakley, I
Williams, LV
Trevethick, MA
机构
[1] Neuroscience, GlaxoWellcome R. and D., Medicines Research Centre, Stevenage
[2] Neuroscience, GlaxoWellcome R. and D., Medicines Research Centre, Stevenage SG1 2NY, Gunnells Road
关键词
D O I
10.1111/j.0953-0673.1996.00339.x
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background: The role of acid in the pathogenesis of indomethacin-induced ulcers of the rat gastric antrum was studied by comparing the effects of pretreating animals with both long-acting (loxtidine, AH22216) and short-acting (ranitidine and cimetidine) inhibitors of acid secretion. Results: Ranitidine and cimetidine were much weaker at inhibiting antral damage when compared to their reported potencies as antisecretory agents. In marked contrast, loxtidine and AH22216 inhibited indomethacin-induced antral ulcers at doses similar to their reported potencies as inhibitors of acid secretion. Histological analysis at doses causing near maximal inhibition of macroscopic damage revealed an almost complete absence of ulcers but a large and significant increase in mucosal damage due to superficial erosions. Hourly dosing with hydrochloric acid reversed the protective effect of ranitidine, cimetidine and loxtidine on macroscopic damage and, histologically, this was associated with the widespread appearance of antral ulcers and a reduction in the proportion of mucosal damage caused by superficial erosions. Conclusions: The results of this study suggest that the pathogenesis of nonsteroidal anti-inflammatory drug (NSAID)-induced antral ulcers involves at least two stages: (1) an initial acid-independent formation of mucosal erosions followed by (2) an acid-dependent conversion of erosions to frank ulcers. Clinically, drugs that suppress acid completely for long periods may be very effective in preventing NSAID-induced gastric antral ulcers.
引用
收藏
页码:339 / 345
页数:7
相关论文
共 27 条
[1]   EFFECTS OF LOXTIDINE, A NEW HISTAMINE H2-RECEPTOR ANTAGONIST, ON 24-HOUR GASTRIC-SECRETION IN MAN [J].
BOYD, EJS ;
WORMSLEY, KG .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1984, 26 (04) :443-447
[2]   HISTAMINE H2-ANTAGONISTS - PAST, PRESENT AND FUTURE [J].
BRITTAIN, RT ;
JACK, D .
JOURNAL OF CLINICAL GASTROENTEROLOGY, 1983, 5 :71-79
[3]   H-2-RECEPTOR ANTAGONISTS PROTECT AGAINST ASPIRIN-INDUCED GASTRIC-LESIONS IN THE RAT [J].
BUNCE, KT ;
DALY, MJ ;
HUMPHRAY, JM ;
STABLES, R .
AGENTS AND ACTIONS, 1981, 11 (1-2) :167-170
[4]  
CLAYTON NM, 1991, GASTROENTEROLOGY, V246, pA22
[5]   SOME INVITRO AND INVIVO ACTIONS OF THE NEW HISTAMINE H2-RECEPTOR ANTAGONIST, RANITIDINE [J].
DALY, MJ ;
HUMPHRAY, JM ;
STABLES, R .
BRITISH JOURNAL OF PHARMACOLOGY, 1981, 72 (01) :49-54
[6]   PREVENTION OF GASTRODUODENAL DAMAGE INDUCED BY NON-STEROIDAL ANTI-INFLAMMATORY DRUGS - CONTROLLED TRIAL OF RANITIDINE [J].
EHSANULLAH, RSB ;
PAGE, MC ;
TILDESLEY, G ;
WOOD, JR .
BRITISH MEDICAL JOURNAL, 1988, 297 (6655) :1017-1021
[7]  
GAW AJ, 1995, ALIMENT PHARM THERAP, V9, P167
[8]   CIRCULATORY MECHANISMS OF GASTRIC-MUCOSAL DAMAGE AND PROTECTION [J].
JACOBSON, ED .
GASTROENTEROLOGY, 1992, 102 (05) :1788-1800
[9]  
LARSSON H, 1983, GASTROENTEROLOGY, V85, P900
[10]   NONSTEROIDAL ANTIINFLAMMATORY DRUG-INDUCED ULCERS - MANAGEMENT BY TRADITIONAL THERAPIES [J].
MCCARTHY, DM .
GASTROENTEROLOGY, 1989, 96 (02) :662-674